Why genomic healthcare data matters in the development of new therapies
Drug Discovery World
NOVEMBER 7, 2022
From a general healthcare perspective, access to this sort of data is invaluable, but this is particularly noteworthy in that DNA tests have historically been limited in these regions on account of cost and availability of practitioners, services and resources.
98 
Let's personalize your content